Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 19, 2002

View Archived Issues

Viragen and U. of Miami collaborate on immune enhancing drug for cancer

Rheumatoid arthritis test receives FDA approval

Serono updates second quarter progress

Oxagen and Pfizer enter target validation collaboration

Enrollment initiated in phase III atamestane trial

British Biotech and GeneSoft enter antibiotics drug discovery collaboration

Columbia submits NDA for testosterone buccal bioadhesive product

New backup compound for AD presented at ACS

MSI-1436 prevents the homeostatic metabolic response induced by decreased feeding in rats

SAR on novel PDE5 inhibitors reported by Pfizer

New ECTA-based antibacterial compounds designed at NewBiotics

Interferon inducers described by Sumitomo and Japan Energy at ACS meeting

Antifungal agents with anti-CaNMT activity designed at Nippon Roche

New 5-HT reuptake inhibitors identified at Lilly

Roche claims novel OSLC inhibitors in recent patent

New GABA-A receptor modulators and their use as anesthetics, sedatives, etc.

New antibacterial compounds in early development at GSK

Antibacterial streptogramin derivatives designed at Aventis Pharma

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026